ConductScience.org, home

Paper6324345

Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Sarngadharan MG and 4 others. Science, 1984. Cited by 1,138 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Papers, record 6324345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6324345

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
PubMed
Journal
Science
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,138
iCite
Relative citation ratio, by iCite
31.1
iCite
Revised in PubMed
2022-04-08
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sarngadharan MGM G
2Popovic MM
3Bruch LL
4Schüpbach JJ
5Gallo RCR C

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Antibodies, ViralMajor topic
DeltaretrovirusMajor topic
Adult
Antigens, Viral
Child, Preschool
Enzyme-Linked Immunosorbent Assay
Female
Homosexuality
Humans
Infant
Male
Middle Aged
Sarcoma, Kaposi
Substance-Related Disorders
T-Lymphocytes
Viral Envelope Proteins

Source PubMed

Cited by244

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,138 citations.

PMIDTitleJournalYearIn PapersSource
42,981,209Before the Trial: Taxonomic Inference, AIDS, and the Limits of Evidence Appraisal.J Eval Clin Pract2026https://conductscience.org/library/papers/42981209PubMed
39,339,960New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.Viruses2024https://conductscience.org/library/papers/39339960PubMed
38,457,490Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38457490PubMed
35,962,033Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.Nat Rev Immunol2023https://conductscience.org/library/papers/35962033PubMed
35,432,297Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective.Front Immunol2022https://conductscience.org/library/papers/35432297PubMed
35,018,404Past and future of HIV infection. A document based on expert opinion.Rev Esp Quimioter2022https://conductscience.org/library/papers/35018404PubMed
33,352,046Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2.J Nat Prod2021https://conductscience.org/library/papers/33352046PubMed
32,291,335The Diversity-Innovation Paradox in Science.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32291335PubMed
30,931,130HIV Apheresis Tags (HIVAT) Aided Elimination of Viremia.Mol Cell Ther2018https://conductscience.org/library/papers/30931130PubMed
30,854,19440 years of the human T-cell leukemia virus: past, present, and future.F1000Res2019https://conductscience.org/library/papers/30854194PubMed
28,535,293Invited Commentary: A Landmark Study Launched in a Public Health Maelstrom.Am J Epidemiol2017https://conductscience.org/library/papers/28535293PubMed
26,862,491Historical review of the causes of cancer.World J Clin Oncol2016https://conductscience.org/library/papers/26862491PubMed
26,637,462A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies.J Virol2016https://conductscience.org/library/papers/26637462PubMed
26,314,853Uncovering HIV-1-infected cells.Oncotarget2015https://conductscience.org/library/papers/26314853PubMed
25,695,040Questioning the HIV-AIDS Hypothesis: 30 Years of Dissent.Front Public Health2014https://conductscience.org/library/papers/25695040PubMed
25,369,611Supportive care in patients with acute leukaemia: historical perspectives.Blood Transfus2015https://conductscience.org/library/papers/25369611PubMed
24,736,215HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.Viruses2014https://conductscience.org/library/papers/24736215PubMed
24,286,556From GRID to gridlock: the relationship between scientific biomedical breakthroughs and HIV/AIDS policy in the US Congress.J Int AIDS Soc2013https://conductscience.org/library/papers/24286556PubMed
24,243,012An integrated overview of HIV-1 latency.Cell2013https://conductscience.org/library/papers/24243012PubMed
24,124,392Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy.Clin Epidemiol2013https://conductscience.org/library/papers/24124392PubMed

See all 244 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MAPK15,594PubTator's text mininghttps://conductscience.org/library/genes/5594

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6324345

GET https://conductscience.org/api/papers/v1/6324345/cited_by?page=2